Breo

Breo (倍轻松) is a Chinese consumer brand in the personal-care appliance space, associated in particular with eye massagers and similar wellness devices. The brand is positioned in the consumer discretionary / consumer durables segment, specifically within personal-care appliances and vision-care devices. The supplied evidence for this dossier is limited: the official website domain mybreo.com currently hosts content for BREO ELLIPTA, a prescription asthma and COPD medicine from GSK, which is a different commercial entity that shares the "Breo" name. Because the evidence does not describe the Chinese personal-care brand's products, ownership, or history in detail, this entry should be treated as a preliminary identity record. Further verification against the brand's own corporate materials is required before the dossier can be considered complete.

• 2026

  Penalized for failure to disclose related-party transactions and other violations

  In July 2026, Breo received a final administrative penalty decision from the Shenzhen Securities Regulatory Bureau over violations including the failure to disclose related-party transactions. The company, its chairman, and other related parties were fined a combined total of more than 10 million yuan.

  Source

• 2026

  Actual controller suspected of manipulating company stock, receives proposed penalty and market ban notice

  In June 2026, Breo's actual controller Ma Xuejun received a prior notice of proposed penalty. Regulators found that he and several others manipulated the company's stock, and proposed a fine and a five-year market ban. This case is separate from the company's information disclosure case and remains at the proposed penalty stage.

  Source

Read more

1. 1BREO homepage | BREO ELLIPTA (fluticasone furoate and vilanterol)mybreo.com
2. 2Penalized for failure to disclose related-party transactions and other violationsstatic.nfnews.com
3. 3Actual controller suspected of manipulating company stock, receives proposed penalty and market ban noticefinance.cnr.cn